Rockefeller Capital Management’s VanEck Biotech ETF BBH Stock Holding History
Bought
Maintained
Sold
Other funds holding BBH
Rockefeller Capital Management's BBH Position: Q3 2026 in Review
Rockefeller Capital Management held its VanEck Biotech ETF (BBH) position steady in Q3 2026 at 11,862 shares worth $2.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1232.
Rockefeller Capital Management first reported a position in BBH in Q4 2018 and has held it in 32 quarters since. 122 funds tracked by Wall St. Rank hold BBH as of Q3 2026.
- Rockefeller Capital Management held 11,862 shares of VanEck Biotech ETF worth $2.9M as of Q3 2026.
- Rockefeller Capital Management left its VanEck Biotech ETF share count unchanged in Q3 2026.
- VanEck Biotech ETF made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q3 2026, its #1232 holding.
- Rockefeller Capital Management first reported a position in VanEck Biotech ETF in Q4 2018 and has held it in 32 quarters since.
- 122 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q3 2026.
Based on Rockefeller Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.